| The catalytic power of enzymes: Conformational selection or transition state stabilization? J Giraldo, D Roche, X Rovira, J Serra FEBS letters 580 (9), 2170-2177, 2006 | 46 | 2006 |
| Assessing receptor affinity for inverse agonists: Schild and Cheng-Prusoff methods revisited J Giraldo, J Serra, D Roche, X Rovira Current drug targets 8 (1), 197-202, 2007 | 31 | 2007 |
| A complementary scale of biased agonism for agonists with differing maximal responses J Burgueño, M Pujol, X Monroy, D Roche, MJ Varela, M Merlos, J Giraldo Scientific reports 7 (1), 15389, 2017 | 30 | 2017 |
| Modeling the binding and function of metabotropic glutamate receptors X Rovira, D Roche, J Serra, J Kniazeff, JP Pin, J Giraldo Journal of Pharmacology and Experimental Therapeutics 325 (2), 443-456, 2008 | 27 | 2008 |
| Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two‐state and operational models D Roche, D Gil, J Giraldo British journal of pharmacology 169 (6), 1189-1202, 2013 | 26 | 2013 |
| Convivencia social e intercultural en territorios de alta diversidad C Giménez, J Lobera, T MORA, D ROCHE Encuesta, 2010 | 24 | 2010 |
| Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system X Rovira, M Vivó, J Serra, D Roche, PG Strange, J Giraldo British journal of pharmacology 156 (1), 28-35, 2009 | 23 | 2009 |
| How do consumers respond to “sin taxes”? New evidence from a tax on sugary drinks E Fichera, T Mora, BG Lopez-Valcarcel, D Roche Social Science & Medicine 274, 113799, 2021 | 21 | 2021 |
| Ecophysiological significance of scale-dependent patterns in prokaryotic genomes unveiled by a combination of statistic and genometric analyses JAL Garcia, F Bartumeus, D Roche, J Giraldo, HE Stanley, EO Casamayor Genomics 91 (6), 538-543, 2008 | 14 | 2008 |
| Multiple active receptor conformation, agonist efficacy and maximum effect of the system: the conformation-based operational model of agonism D Roche, D Gil, J Giraldo Drug discovery today 18 (7-8), 365-371, 2013 | 13 | 2013 |
| City characteristics that attract Airbnb travellers: evidence from Europe B Güçlü, D Roche, F Marimon International Journal for Quality Research, 2020 | 11 | 2020 |
| Convivencia social e intercultural en territorios de alta diversidad C Giménez Romero, J Lobera, T Mora, D Roche Barcelona: Obra Social ‘la Caixa, 2014 | 11 | 2014 |
| Have many estimates of efficacy and affinity been misled? Revisiting the operational model of agonism D Roche, PH van der Graaf, J Giraldo Drug discovery today 21 (11), 1735-1739, 2016 | 10 | 2016 |
| Mathematical modeling of G protein-coupled receptor function: what can we learn from empirical and mechanistic models? D Roche, D Gil, J Giraldo G Protein-Coupled Receptors-Modeling and Simulation, 159-181, 2014 | 10 | 2014 |
| Detecting loss of diversity for an efficient termination of EAs D Roche, D Gil, J Giraldo 2013 15th International Symposium on Symbolic and Numeric Algorithms for …, 2013 | 7 | 2013 |
| Do consumers respond to ‘sin taxes’ heterogeneously? New evidence from the tax on sugary drinks using longitudinal scanner data T Mora, E Fichera, BG Lopez-Valcarcel, D Roche Working paper, 2018 | 6 | 2018 |
| Using statistical inference for designing termination conditions ensuring convergence of Evolutionary Algorithms. D Roche, D Gil, J Giraldo ECAL, 680-687, 2011 | 5 | 2011 |
| An inference model for analyzing termination conditions of evolutionary algorithms D Roche, D Gil, J Giraldo Artificial Intelligence Research and Development, 218-227, 2011 | 5 | 2011 |
| Predicting the onset of diabetes-related complications after a diabetes diagnosis with machine learning algorithms T Mora, D Roche, B Rodríguez-Sánchez Diabetes Research and Clinical Practice 204, 110910, 2023 | 4 | 2023 |
| Terminating evolutionary algorithms at their steady state D Gil, D Roche, A Borràs, J Giraldo Computational Optimization and Applications 61, 489-515, 2015 | 4 | 2015 |
